Laboratory and clinical experience with clotrimazole (Bay b 5097).
D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D001230:Aspergillus / Q000187:drug effects*; D001231:Aspergillus flavus / Q000187:drug effects; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects*; D002986:Clinical Trials as Topic; D005260:Female; D006118:Griseofulvin / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D003904:Mitosporic Fungi / Q000187:drug effects*; D008271:Mycetoma / Q000188:drug therapy*; D010304:Paronychia / Q000188:drug therapy*
D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles; D006118:Griseofulvin